Skip to content

Switch to nevirapine safe for treatment-experienced patients with high CD4 cell counts

Nelfinavir shows promise as a cancer therapy

Patients with cryptococcus who start HAART may develop an IRIS up to three years later

Apricitabine strong in phase 2 study, 24-week data released

One in four HIV patients feel stigmatised by healthcare staff

A follow-up on follow-up: shifting to a community-based response to improve retention in care

Difficulties in implementing infant feeding guidelines

Heavy drinkers living with HIV have lower CD4 counts

Emergence of CXCR4-tropic HIV raises risk of AIDS fourfold